EUDA: The OPTIMUS Guidance on Opioid Agonist Maintenance Treatment (OMT) outcomes monitoring Authors: the OPTIMUS* Study Group Aktualisiert zum 07.07.2026 https://drive.google.com/file/d/1ZZWVo_Gwbqh7DfOIxlI-50ODIj-S9nRf/view

Health-related quality of life measures as predictors for recurrent hospitalization and mortality among patients in heroin-assisted treatment.  Melis F, Kvamme TL, Tjagvad C, Eide D, Thylstrup B, Clausen T, Hesse M.  Qual Life Res. 2025…

Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel.  Brandt J, Lamberson N, Bressi J, Ritvo A, Curle J, Witt-Doerring J, DeWert M, W…

Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-Analysis.  Shim SR, Jeong HS, Bommersbach TJ, et al.  JAMA Psychiatry. 2026;83(7):714–731. doi:10.1001/j…

Amanita muscaria in the evolving novel psychoactive substances landscape - toxicological risks and clinical implications: a narrative review.  Ordak M.  Front Pharmacol. 2026 May 26;17:1838212. doi: 10.3389/fphar.2026.1838212. PMID: 4227…

The RESPONDER trial: a feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses in Skåne, Sweden.  Rehn J, Andréll C, Hansson J, Troberg K, Isendahl P…